MedTrace Logo

Appetite Suppression Trial With Polydextrose

NCT02064205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-06-06

Study results available
· View outcomes & findings →

Summary

Overweight and obesity are a global epidemic, which causes a rapid increase in the frequency of diabetes and cardiovascular diseases. Food ingredients that influence the mechanisms that regulate satiety may play a role in weight management. Suppression of appetite may reduce energy intake, which in return may lead to body weight reduction. This study aims to verify the appetite suppressive effect of polydextrose in comparison to a placebo in normal weight and overweight women.

Conditions

  • Body Weight
  • Non-restrained Eaters

Interventions

DIETARY_SUPPLEMENT

12.5 g polydextrose

Appetite suppressing supplement is added in yogurt and provided with breakfast (four hours before lunch) or 1.5h before lunch. Also yogurt with control (glucose syrup) is tested for its satiating effect.

DIETARY_SUPPLEMENT

glucose syrup

Glucose syrup is used a control product for the polydextrose

Sponsors & Collaborators

  • W.J. Pasman

    lead OTHER

Principal Investigators

  • Naguib Muhsen, MD · QPS, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-10-31
Completion
2014-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064205 on ClinicalTrials.gov